0001209191-14-007834.txt : 20140206 0001209191-14-007834.hdr.sgml : 20140206 20140206085327 ACCESSION NUMBER: 0001209191-14-007834 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140205 FILED AS OF DATE: 20140206 DATE AS OF CHANGE: 20140206 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 252025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-871-9911 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TRV GP, LLC CENTRAL INDEX KEY: 0001578973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 14578149 BUSINESS ADDRESS: STREET 1: C/O THIRD ROCK VENTURES STREET 2: 29 NEWBURY STREET, 3RD FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-585-2000 MAIL ADDRESS: STREET 1: C/O THIRD ROCK VENTURES STREET 2: 29 NEWBURY STREET, 3RD FLOOR CITY: BOSTON STATE: MA ZIP: 02116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Third Rock Ventures GP, L.P. CENTRAL INDEX KEY: 0001578976 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 14578150 BUSINESS ADDRESS: STREET 1: C/O THIRD ROCK VENTURES STREET 2: 29 NEWBURY STREET, 3RD FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-585-2000 MAIL ADDRESS: STREET 1: C/O THIRD ROCK VENTURES STREET 2: 29 NEWBURY STREET, 3RD FLOOR CITY: BOSTON STATE: MA ZIP: 02116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: THIRD ROCK VENTURES LP CENTRAL INDEX KEY: 0001408591 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 14578151 BUSINESS ADDRESS: STREET 1: 29 NEWBURY STREET STREET 2: SUITE 401 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-859-3099 MAIL ADDRESS: STREET 1: 29 NEWBURY STREET STREET 2: SUITE 401 CITY: BOSTON STATE: MA ZIP: 02116 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2014-02-05 0 0001485003 Eleven Biotherapeutics, Inc. EBIO 0001408591 THIRD ROCK VENTURES LP 29 NEWBURY STREET BOSTON MA 02116 0 0 1 0 0001578976 Third Rock Ventures GP, L.P. 29 NEWBURY STREET BOSTON MA 02116 0 0 1 0 0001578973 TRV GP, LLC 29 NEWBURY STREET BOSTON MA 02116 0 0 1 0 Common Stock 330708 D Series A Preferred Stock Common Stock 3267716 D Series B Preferred Stock Common Stock 481619 D Common Stock Warrant (right to purchase) 0.0635 Common Stock 127077 D Common Stock Warrant (right to purchase) 0.0635 Common Stock 82989 D The Series A Preferred Stock is convertible into Common Stock on an 6.35-for-one basis into the number of shares of Common Stock as shown in column 3 at any time at the holder's election, and automatically upon the closing of the Issuer's initial public offering, and has no expiration date. The general partner of Third Rock Ventures, L.P. is Third Rock Ventures GP, LP ("TRV GP"). The general partner of TRV GP is Third Rock Ventures GP, LLC ("TRV GP, LLC"). TRV GP and TRV GP, LLC disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein. The Series B Preferred Stock is convertible into Common Stock on an 6.35-for-one basis into the number of shares of Common Stock as shown in column 3 at any time at the holder's election, and automatically upon the closing of the Issuer's initial public offering, and has no expiration date. The Warrant to purchase Common Stock as shown in column 3 is exercisable at any time at the holder's election prior to June 28, 2018, and automatically upon the closing of the Issuer's initial public offering. The Warrant to purchase Common Stock as shown in column 3 is exercisable at any time at the holder's election prior to December 4, 2018, and automatically upon the closing of the Issuer's initial public offering. /s/ Kevin Gillis, Manager 2014-02-06 By: Third Rock Ventures GP, L.P., its general partner By: TRV GP, LLC, its general partner By: /s/ Kevin Gillis Kevin Gillis, Manager 2014-02-05 By: TRV GP, LLC, its general partner By: /s/ Kevin Gillis, Manager 2014-02-05